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Fluorescencea b s t r a c t
The inducible transcription factor Egr-1 binds speciﬁcally to 9-bp target sequences containing two
CpG sites that can potentially be methylated at four cytosine bases. Although it appears that com-
plete CpG methylation would make an unfavorable steric clash in the previous crystal structures
of the complexes with unmethylated or partially methylated DNA, our afﬁnity data suggest that
DNA recognition by Egr-1 is insensitive to CpG methylation. We have determined, at a 1.4-Å resolu-
tion, the crystal structure of the Egr-1 zinc-ﬁnger complex with completely methylated target DNA.
Structural comparison of the three different methylation states reveals why Egr-1 can recognize the
target sequences regardless of CpG methylation.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction factors. Conversely, the transcription factors can protect boundDNA methylation at the C5 position of cytosine bases in CpG
dinucleotides by DNA methyltransferases is common in higher
eukaryotes, particularly vertebrates [1]. A majority of gene pro-
moters involve regions called CpG islands, where CpGs are present
at a high density but rarely methylated [2–5]. Interestingly,
although the overall methylation level of CpGs in human genomic
DNA is 70–80% [6], methylation levels in CpG islands are typically
less than 10% for active genes. CpG methylation in promoters gen-
erally causes gene repression, and is considered to play important
roles in development [2,7]. Not surprisingly, abnormality in CpG
methylation is associated with major diseases such as cancer [8],
atherosclerosis [9], and schizophrenia [10].
Cross-talk between site-speciﬁc transcription factors and DNA
methylation states is considered to play an important role in gene
regulation via CpG methylation [5,11–13]. Some transcription fac-
tors, including those of Ets, zinc-ﬁnger, Myc, E2F, and ATF families,
recognize DNA sequences containing CpG [12]. Methylation of
their target DNA sites can potentially affect these transcriptionDNA regions from methylation [5,12]. In fact, the transcription fac-
tors Sp1 and CTCF are known to block methylation and maintain
the low methylation level of the CpG island promoters [14–16].
This protection is possible because these transcription factors are
constitutively expressed. For inducible transcription factors, how-
ever, their target sequences could become methylated more easily
because these proteins are only transiently expressed upon partic-
ular stimuli to the cells.
Our current study is focused on the impact of methylation
within target DNA on speciﬁc complex formation of the inducible
transcription factor Egr-1 (also known as Zif268). This protein rec-
ognizes 9-bp sequences GCGTGGGCG via three zinc-ﬁnger (ZF)
domains [17,18]. In the brain, Egr-1 is induced via synaptic signals
and plays an important role in long-term memory formation and
consolidation [19,20]. In the cardiovascular system, Egr-1 serves
as a stress-inducible transcription factor that initiates defense
against vascular stress [21,22]. The Egr-1 target sequences contain
two CpGs. It is known that methylation of these CpGs in the Egr-1
target sites causes repression of some genes in vivo [23–26]. To
better understand this effect, the impact of CpG methylation on
DNA recognition by Egr-1 should be investigated at both molecular
and atomic levels.
For this purpose, we compare the dissociation constants and the
three-dimensional structures of the Egr-1 zinc-ﬁnger DNA com-
plexes containing distinct numbers of 5-methylcytosine (5mC)
bases at the CpG sites. We show that Egr-1’s binding to the target
DNA is insensitive to CpG methylation although the two CpGs are
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structure at a 1.4 Å resolution of the Egr-1 zinc-ﬁnger–DNA com-
plex in which all the four cytosine bases of the two CpGs in the tar-
get are methylated. Comparison of this structure with the other
high-resolution structures of the complexes containing no or fewer
5mC bases explains why Egr-1 can recognize the target sequences
regardless of CpG methylation states.
2. Materials and methods
2.1. Preparation of protein and DNA
The sequences of the protein and DNA are shown in Fig. 1A. The
residue numbering schemes adopted in this paper are according to
those of Elrod-Erickson et al. [17]. The Egr-1 zinc-ﬁnger protein
was prepared as previously described [27–30]. Protein concentra-
tion was measured with BCA protein assay kit (Pierce). Individual
DNA strands were purchased from Integrated DNA Technologies
and puriﬁed with a Mono-Q anion-exchange column (GE
Healthcare). After annealing of the complementary strands, the
DNA duplexes were puriﬁed using Mono-Q anion-exchange chro-
matography to remove any excess amount of single-stranded
DNA, as described [31].
2.2. Binding afﬁnity measurements
Afﬁnities of the Egr-1 zinc-ﬁnger protein for the unmethylated,
partially methylated, and completely methylated target DNA
duplexes were determined using ﬂuorescence anisotropy as a func-
tion of protein concentration (0.1–2000 nM). Fluorescence arising
from tetramethylrhodamine (TAMRA) attached to the 30-terminus
of DNA (10 nM) was measured using an ISS PC-1 spectroﬂuorome-
ter, as described [27]. The assays were performed at 20 C using a
buffer of 10 mM Tris–HCl pH 7.5 and 150 mM KCl. The dissociation
constant Kd was calculated from the anisotropy data via non-linear
least-squares ﬁtting with:Fig. 1. Egr-1 is insensitive to CpG methylation within the target DNA, although two CpGs
this study. Numberings of protein and DNA residues are according to Pabo and co-wor
measured by the ﬂuorescence anisotropy-based titration experiment. Fluorescence aniso
protein concentration. (C) Competition binding assays using the protein (50 nM), TAMRA
anisotropy for the TAMRA-labeled DNA was measured as a function of the competitor co
bound state, which were obtained from the anisotropy data. Magenta, blue, and black
unmethylated DNA duplexes, respectively, in the panels B and C. (D) The 1.4-Å-resolution
containing four 5mC bases. The structure of this complex (green) is superposed onto
methylated (4R2A) DNA (gray). The methyl groups of 5mC and zinc ions of the completAobs ¼ Afree þ ðAbound  AfreeÞ Ptot þ Dtot þ Kdð

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðPtot þ Dtot þ KdÞ2  4PtotDtot
q 
=ð2DtotÞ ð1Þ
where Aobs is the observed anisotropy; Abound and Afree are those of
protein-bound DNA and free DNA; and Ptot and Dtot are total concen-
trations of the protein and the probe DNA, respectively. For each
DNA, the afﬁnity measurements were repeated three times.
We also measured Kd values using a ﬂuorescence-based compe-
tition assay. First, we prepared a solution of 10 nM
30-TAMRA-labeled target DNA and 50 nM Egr-1, in which the vast
majority (> 99%) of the probe DNA is in the protein-bound state.
Then, we titrated this solution with unlabeled competitor DNA
and monitored a change in ﬂuorescence anisotropy as a function
of the competitor concentration (0.1–256 lM). The competitor
DNA used in this assay was a 12-bp DNA duplex with the sequence
of 50-TATGTAGGCGGT-30, which is similar to the Egr-1 target. We
determined the dissociation constants from competitor titration
data using the following equation:
Aobs ¼
ð1þ Ctot=KdðcompÞÞAfree þ ðPtot=KdðprobeÞÞAbound
1þ Ctot=KdðcompÞ þ Ptot=KdðprobeÞ ð2Þ
where Kd(comp) and Kd(probe) are the dissociation constants for the
competitor and probe DNA duplexes, respectively, and Ctot is the
concentration of the competitor DNA. Eq. (2) is valid only under
the conditions of Dtot Ptot  Ctot. The Kd(comp) constant was sepa-
rately measured by a protein titration assay using a
30-TAMRA-labeled version of the competitor DNA.
2.3. Crystallization of the completely methylated DNA complex of
Egr-1
A solution of the Egr-1 zinc-ﬁnger protein was mixed with a
solution of the DNA duplex containing four 5mC bases at the two
CpG sites in the target sequence at a 1:1.1 ratio of protein to
DNA. Using Amicon Ultra (Millipore), the complex wasare present at the interfaces. (A) Sequences of the protein and DNA duplexes used in
kers [17,18]. Positions of 5mC bases are indicated in red. (B) Binding isotherm as
tropy for TAMRA-labeled 12-bp duplexes (10 nM) was measured as a function of the
-labeled 12-bp target DNA duplex (10 nM), and unlabeled competitor. Fluorescence
ncentration. The vertical axis is for factions of TAMRA-labeled DNA in the protein-
circles represent data points for completely methylated, partially methylated, and
crystal structure of the Egr-1 zinc-ﬁnger complex with completely methylated DNA
the crystal structures of the complexes with unmethylated (1AAY) or partially
ely methylated DNA complex are shown in red and yellow, respectively.
Table 1
Crystallographic data collection and reﬁnement statistics.
Crystallographic data collection
X-ray source APS 21-ID-F
Wavelength (Å) 0.97872
Space group C2221
Unit cell parameters (Å, ) a = 44.01, b = 55.99, c = 128.95,
a = b = c = 90
Sample temperature (K) 100
Resolution range (Å) 30.49–1.41
Total reﬂections 46629
Non-anomalous reﬂections 26831







Bond RMSD from ideal values
(Å)
0.013












a Numbers in parentheses are values for the last shell (1.42–1.40 Å).
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(pH 8.0) and 500 mM NaCl. The high-concentration solution was
mixed with a reservoir buffer of 25 mM bis-trispropaneHCl (pH
8.0), 350–550 mM NaCl, and 6–10% PEG 400, as described by
Pavletich and Pabo [18]. Crystals were grown at 17 C over 2 weeks
using the sitting-drop vapor diffusion method.
2.4. Crystallographic data collection and structure determination
The data were collected using a Mar Mosaic 225 detector at the
Advance Photon Source (APS) beamline 21-ID-F (wavelength,
0.97872 Å) at Argonne National Laboratory. In order to produce
complete high-resolution data with high multiplicity, datasets
were collected from 4 crystals, but one was discarded due to
non-isomorphism. Each dataset consisted of 360 frames of 1/2
width, with varying resolution. Images were processed and scaled
with HKL2000. An analysis of the merging CC1/2 indicated that the
resolution was limited by the detector distance and geometry, as
was the completeness in the high resolution bins. Reﬁnement,
starting from the 4R2A structure, was performed using Phenix
[32], with TLSMD [33] determined TLS parameters, weight opti-
mization, and DNA restraints. Model building and validation was
performed in Coot [34]. The atomic coordinates of the crystal struc-
ture have been deposited in the PDB with accession code 4X9J.
3. Results
Before our current study, two crystal structures of the Egr-1
zinc-ﬁnger–DNA complexes different in terms of DNA methylation
were available. One was a 1.6-Å-resolution structure of the com-
plex with unmethylated DNA (PDB 1AAY) [17]. The other was the
1.6-Å-resolution structure of the complex in which only one of
the two CpGs in the target DNA is methylated (PDB 4R2A) [35]. If
cytosine-3 (Cyt3) is methylated in these structures, the added
CH3 is too close to the E77 Cc atom and creates a steric clash with
a C. . .C distance (2.4 Å) shorter than the sum of van der Waals
radii (3.4 Å). Given this, one may expect that methylation of the
second CpG would diminish Egr-1–DNA association. However, as
demonstrated below, our data show that Egr-1 is capable of recog-
nizing the target sequence regardless of the CpG methylation state.
3.1. Impact of CpG methylation on binding afﬁnities of the Egr-1 zinc-
ﬁnger protein
Using two different ﬂuorescence-based assays, we examined
the inﬂuence of CpG methylation on Egr-1’s binding to the target
DNA at physiological ionic strength (i.e., 150 mM KCl). By protein
titration assays, in which TAMRA ﬂuorescence anisotropy is moni-
tored as a function of the protein concentration, we directly mea-
sured the dissociation constants Kd for the complexes with 12 bp
DNA duplexes in different methylation states (Fig. 1B). The Kd val-
ues for the complexes with the unmethylated, partially methy-
lated, and completely methylated DNA duplexes were
determined to be 6 ± 1, 7 ± 1, and 10 ± 2 nM, respectively, suggest-
ing that Egr-1 is insensitive to CpG methylation.
Because these Kd values were close to the lower limit of the
measurable range in the protein titration assay, we also analyzed
afﬁnities by competition assays that allow for Kd determination
for high afﬁnity systems. In these assays, a solution of the complex
of the protein and ﬂuorescent DNA was initially made, and an unla-
beled 12-bp DNA duplex with a weaker afﬁnity was added as the
competitor. The ﬂuorescence anisotropy changes as the unlabeled
competitor increasingly outcompetes the probe DNA (Fig. 1C).
From these data together with the afﬁnity of the competitor DNA
(Kd = 29 ± 3 nM), we determined the Kd values for theunmethylated, partially methylated, and completely methylated
complexes to be 5.1 ± 0.3, 6.1 ± 0.3, and 4.9 ± 0.3 nM, respectively.
Thus, both datasets indicate that Egr-1 can recognize the target
DNA regardless of its methylation state, although the CpG sites
are at the protein–DNA interfaces.
3.2. Overall structure of the completely methylated DNA complex of
Egr-1
To investigate structural impact of complete CpG methylation
within the target DNA, we determined at a 1.4-Å resolution the
crystal structure of the Egr-1 zinc-ﬁnger protein bound to com-
pletely methylated DNA containing four 5mC bases at the two
CpG sites. The structure of the complex, involving 208 water mole-
cules, was reﬁned to Rwork = 17% and Rfree = 20%. Other information
on crystallographic data and reﬁnement are given in Table 1. In
Fig. 1D, this structure is superimposed onto the crystal structures
of the complexes with unmethylated DNA (PDB 1AAY) or with par-
tially methylated DNA containing two 5mC base (PDB 4R2A). As is
evident from this superimposition, the overall structures in these
three states are very similar: the values of root-mean-square devi-
ation (RMSD) of atomic positions for the protein and DNA backbone
were 0.71 Å for the completely methylated vs. unmethylated DNA
complexes and 0.50 Å for the completely methylated vs. partially
methylated DNA complexes. These results indicate that DNA
methylation does not signiﬁcantly alter the overall structure of
the complex. However, owing to the high-resolution data, we were
able to identify signiﬁcant structural differences and common fea-
tures in great details, as described below.
3.3. Egr-1’s structural plasticity to recognize target sequences
regardless of methylation states
As mentioned above, simplistic addition of a CH3 group to Cyt3
of the crystal structures of the unmethylated (1AAY) or partially
Fig. 3. Two 5mC-Arg-G triads in the 1.4 Å resolution crystal structure of the Egr-1
complex with completely methylated DNA. The electron density map together with
ball and stick representation are shown for the triads formed by 5mC3, R74, and
Gua4 (the panel A) and by 5mC9, R18, and Gua10 (the panel B). The hydrogen bonds
between Arg and G are indicated with a dotted line. The 5mC-Arg-G triad motif is
commonly found in three-dimensional structures of the proteins that speciﬁcally
recognize methyl-CpG DNA [39].
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side chain of zinc ﬁnger 3 (ZF3). However, our crystal structure
of the completely methylated complex shows that Egr-1 adapts
the conformation of the E77 side chain so that favorable interac-
tions are made with the methylated DNA (Fig. 2A). By this adap-
tion, which accompanies changes in the v1 and v3 torsion angles
by 98 and 84, respectively, the E77 Cc methylene group makes
hydrophobic interactions with the CH3 group of the 5mC3 base
and the Cd atom of the F72 aromatic ring. A similar conformational
change upon methylation of Cyt9 is also seen for E21, the corre-
sponding residue in ZF1 that interacts with the other CpG site
(Fig. 2B). Just as seen for the Cyt3–E77 interaction, methylation
of Cyt9 causes a change in the E21 v1 and v3 torsion angles by
105 and 60, respectively, whereby the E21 side chain makes
van der Waals contact with the CH3 group of the 5mC3 base and
the F16 aromatic ring. The conformational change of the E21 side
chain is also found between the structures of unmethylated and
partially methylated DNA complexes. These results show that the
structural plasticity of Egr-1 allows for target recognition insensi-
tive to CpG methylation.
3.4. Role of hydration water in methylation-insensitive recognition of
target by Egr-1
In general,methyl groups ofmethyl-CpGs arewell hydrated [36].
Recent crystallographic studies suggest that hydration around the
5mC methyl groups plays important roles in DNA recognition by
methyl-CpG-binding domain (MBD) proteins such as MeCP2 and
MBD4 [37,38]. Taking advantage of the high-resolution structures
in the three different methylation states, we examined how the
hydration water molecules are involved in methylation-insensitive
recognition of target DNA by Egr-1. Around cytosine bases in DNA,Fig. 2. Structural changes at the Egr-1 zinc-ﬁnger–DNA interfaces upon CpG
methylation. Carbon bonds and hydration water molecules are shown in green for
the completely methylated DNA complex; in white for the partially methylated
DNA complex; and in purple for the unmethylated DNA complex. Curved arrows
show methylation-induced changes in the E77 and E21 side-chain conformations.
Water molecules at the canonical hydration positions (wA and wB) for Cyt and 5mC
bases [36] are shown. Dotted arrows show methylation-induced changes in
hydration.there are twomajorhydration sites,whichMayer-Junget al. referred
to as wA and wB [36]. Upon CpG methylation, the position of wB is
shifted toward DNA phosphate while the position of wA is virtually
unaffected [36]. Fig. 2 shows wA and wB water molecules around
CpG cytosine bases in the three Egr-1 zinc-ﬁnger–DNA complexes.
Cyt40 (5mC40) and Cyt100 (5mC100) bases, which are not in direct
contact with the protein, exhibit canonical hydration at the wA
andwB positions. A shift of wB uponmethylation (indicated by dot-
ted arrows in Fig. 2) is also seen for these bases. For Cyt3 (5mC3) and
Cyt9 (5mC9) bases, the interaction with the E77 or E21 side chain
perturbs wB. Interestingly, due to this perturbation, both unmethy-
lated and methylated states exhibit the wB water molecules in the
same region. Regardless of DNA methylation, the water molecules
wA at these bases remain at the same position, and importantly,
formhydrogen bondswith the D76 or D20 side chain aswell aswith
the other wAwatermolecule in the same CpG dinucleotide. Thus, in
the target recognition, Egr-1 uses the samewater-mediated interac-
tions that areunaffectedbyCpGmethylation. This featureappears to
be important for Egr-1’s capability of recognizing the target DNA
regardless of CpG methylation states.
3.5. 5mC-Arg-G triads at the two CpG sites
Liu et al. recently identiﬁed a structural motif, ‘‘5mC-Arg-G tri-
ads’’, common to the proteins bound to DNA at methylated CpGs
[39]. In this structural motif, the methyl group of a 5mC makes
van der Waals contact with the guanidino moiety of the Arg
side-chain that forms two hydrogen bonds with 30-guanine (Gua)
base of methylated CpG. This structural motif is commonly found
in currently available crystal structures of methyl-CpG DNA–pro-
tein complexes [35,37,38,40–42]. Our crystal structure of the com-
pletely methylated DNA complex of Egr-1 also shows two
5mC-Arg-G triads: one with 5mC3, R74, and Gua4 (Fig. 3A), and
the other with 5mC9, R18, and Gua10 (Fig. 3B). The center dis-
tances between the Cyt pyrimidine rand Arg Ng1/Ng2 groups
are 3.7 and 3.8 Å for the 5mC3-R74 and 5mC9-R18 pairs, respec-
tively, suggesting that these 5mC-Arg-G triads are stabilized by
the cation–p interactions [43]. The presence of this structural motif
at each CpG methylation site suggests that Egr-1 is well suited to
recognize the methylated target sequences.
4. Discussion
Our current study shows that, even when the target sequence is
completely methylated at the two CpG sites, Egr-1 can adapt its
conformation to recognize the target DNA and retain the same
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function is insensitive to DNA methylation in vivo as well.
However, some studies suggest otherwise. For example, CpG
methylation of Egr-1 sites causes repression of the protein kinase
Ce (PKCe) gene in the heart [23,24,26]. A decreased level of CpG
methylation in the Egr-1 target site causes hyperactive expression
of the heparanase gene in bladder cancer [25]. These in vivo data
suggest that the CpG methylation in the Egr-1 target site causes
a decrease in expression of some target genes. Why can this occur,
although Egr-1 retains its intrinsic binding afﬁnity for the target
sites regardless of methylation?
We speculate that this discrepancy between the in vitro and
in vivo data could be due to competition with proteins that bind
speciﬁcally to methyl-CpGs. In fact, blocking of transcription fac-
tors by MBD proteins has been proposed as an indirect mechanism
for gene repression [5]. For example, the MeCP2 protein is abun-
dant in many cell types and causes gene repression via its tran-
scriptional repression domain [44,45]. Judging from the crystal
structure of the MeCP2 MBD–DNA complex [37], simultaneous
binding of Egr-1 and MeCP2 to the same sites appears impossible,
and therefore, Egr-1 should compete with MeCP2 for the methy-
lated target sequences. When the Egr-1 target sites are methylated,
MeCP2 could outcompete Egr-1 for these sites due to the abun-
dance of MeCP2. In this indirect manner, CpG methylation of
Egr-1 sites can still cause gene repression even though the CpG
methylation itself does not directly affect binding afﬁnities of
Egr-1 for the target sequences. Additional studies are required to
examine this hypothetical mechanism.
It should be noted that CpG methylation is known to directly
impact some other zinc-ﬁnger proteins even in vitro. For example,
the C2H2 zinc-ﬁnger proteins Kaiso and Zfp57 exhibit substantially
stronger afﬁnity for CpG-methylated target DNA [46,47]. In con-
trast, the CXXC zinc-ﬁnger protein Cfp1 is known to selectively
bind to unmethylated CpGs [48]. Recent crystallographic studies
on the DNA complexes of these zinc-ﬁnger proteins provide struc-
tural basis for the direct impact of CpG methylation [40,42,49]. Our
current study shows that, unlike these proteins, Egr-1 is insensitive
to CpGmethylation of its target DNA sequences, owing to its ability
to adapt the side-chain conformations depending on the methyla-
tion states of the two CpGs. Other studies also show a relatively
minor impact of CpG methylation on other C2H2 zinc-ﬁnger pro-
teins, Wilms tumor protein 1 (WT1) [35] and Krüppel-like factor
4 (Klf4) [41]. Thus, there are diverse impacts of CpG methylation
on transcription factors, even within the zinc-ﬁnger family alone.
This diversity might be important for elaborate epigenetic pro-
gramming in higher eukaryotes such as mammals.
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